Navigating the hype and hope of psychedelic medicine

Psychiatrist, internist, and addiction medicine specialist Muhamad Aly Rifai discusses his article "Psychedelic-assisted therapy: science, safety, and regulation." Muhamad explores the complex landscape of psychedelic medicine, balancing the growing public interest with the necessity of rigorous FDA oversight and safety protocols. The conversation examines the distinction between classic psychedelics like psilocybin and dissociatives like ketamine while highlighting why "set and setting" are critical for therapeutic success in treating depression and trauma. Muhamad emphasizes that these powerful agents are not simple pill swaps but require structured psychological support to translate peak experiences into lasting behavioral change. Discover why the path to effective treatment relies on transparent regulation and clinician humility rather than unsupervised experimentation. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended